Work

EP.17A.01 The Cumulative Incidence of Brain Metastases in US Medicare Patients with ALK+ mNSCLC Treated with Second-generation ALK TKIs

Year: 2024

Type: article

Study design: Observational Study

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2024.09.1352

Authors: L. Bazhenova, D. Abrahami, K. Ramaswamy, B. Li, M. Davis, A.J. Epstein, Z.A. Marcum, N. Rifi, J. Kelton, K. Duncan, D. Uprety

Institutions: Moores Cancer Center, Pfizer (United States), The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4403469470

FWCI:

Cites:

Cited by:

Related to: 10